• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Glistening-free, hydrophobic acrylic IOL debuts

Article

A new glistening-free, hydrophobic acrylic IOL (enVista, Bausch + Lomb) debuted at the annual meeting of the European Society of Cataract and Refractive Surgeons here.

Vienna, Austria-A new glistening-free, hydrophobic acrylic IOL (enVista, Bausch + Lomb) debuted at the annual meeting of the European Society of Cataract and Refractive Surgeons here.

The lens’ aspheric, aberration-free technology (Advanced Optics, Bausch + Lomb) is designed to deliver enhanced contrast sensitivity and better vision quality, and its 360° square-edge barrier design aims to provide an effective optic-haptic junction to minimize posterior capsular opacification.

“We are proud to innovate the hydrophobic lens category with an IOL that provides a high quality of vision and addresses the common issue of glistenings,” said Robert Grant, chief executive officer and president of global surgical business for Bausch + Lomb. “It was important that we deliver an advanced hydrophobic lens that surgeons and patients can count on now and over the long term, and data [show] that we have achieved that.”

The hydrophobic lens has received CE mark approval in the European Union. Additional approvals are pending worldwide, according to the company.

For more articles in this issue of

Ophthalmology Times Conference Brief

click here

.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.